These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28981492)

  • 1. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
    Robinson T; Jackson R; Wells S; Kerr A; Marshall R
    N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.
    Finnikin S; Ryan R; Marshall T
    Br J Gen Pract; 2017 Dec; 67(665):e881-e887. PubMed ID: 29061715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.
    Fleetcroft R; Schofield P; Ashworth M
    BMC Health Serv Res; 2014 Sep; 14():414. PubMed ID: 25240604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting.
    Chia YC; Lim HM; Ching SM
    BMC Fam Pract; 2014 Nov; 15():172. PubMed ID: 25388219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study.
    Homer K; Boomla K; Hull S; Dostal I; Mathur R; Robson J
    Br J Gen Pract; 2015 Aug; 65(637):e538-44. PubMed ID: 26212850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
    Wallach-Kildemoes H; Stovring H; Holme Hansen E; Howse K; Pétursson H
    J Eval Clin Pract; 2016 Apr; 22(2):235-46. PubMed ID: 26446680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
    van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
    Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.
    Schilling C; Mortimer D; Dalziel K; Heeley E; Chalmers J; Clarke P
    Pharmacoeconomics; 2016 Feb; 34(2):195-205. PubMed ID: 26578402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population health impact of statin treatment in Canada.
    Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
    Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare.
    Hyun KK; Redfern J; Patel A; Peiris D; Brieger D; Sullivan D; Harris M; Usherwood T; MacMahon S; Lyford M; Woodward M
    Heart; 2017 Apr; 103(7):492-498. PubMed ID: 28249996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
    Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
    Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1).
    Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S
    N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting statin prescribing for primary prevention: a historical cohort study.
    Finnikin S; Willis BH; Ryan R; Evans T; Marshall T
    Br J Gen Pract; 2021; 71(704):e219-e225. PubMed ID: 33558331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives.
    Jaspers NEM; Visseren FLJ; Numans ME; Smulders YM; van Loenen Martinet FA; van der Graaf Y; Dorresteijn JAN
    BMJ Open; 2018 May; 8(5):e021309. PubMed ID: 29804065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of the NHS Health Check programme in an urban setting.
    Artac M; Dalton AR; Majeed A; Car J; Huckvale K; Millett C
    Fam Pract; 2013 Aug; 30(4):426-35. PubMed ID: 23377607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.